Restaging after chemoradiotherapy for locally advanced esophageal cancer | Zendy

Ingmar L. Defize | Zendy; Richard van Hillegersberg | Zendy; Stella Mook | Zendy; Gert J. Meijer | Zendy; Steven H. Lin | Zendy; Jelle P. Ruurda | Zendy; Peter S.N. van Rossum | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Restaging after chemoradiotherapy for locally advanced esophageal cancer

Author(s) -

Ingmar L. Defize,

Richard van Hillegersberg,

Stella Mook,

Gert J. Meijer,

Steven H. Lin,

Jelle P. Ruurda,

Peter S.N. van Rossum

Publication year - 2019

Publication title -

annals of translational medicine

Language(s) - English

Resource type - Journals

eISSN - 2305-5847

pISSN - 2305-5839

DOI - 10.21037/atm.2019.11.57

Subject(s) - medicine , chemoradiotherapy , esophageal cancer , modalities , metastasis , treatment modality , radiology , cancer , radiation therapy , surgery , social science , sociology

Restaging after chemoradiotherapy (CRT) for locally advanced esophageal cancer is a pivotal part of modern treatment individualization. de Gouw et al . performed a systematic review and meta-analysis determining the value of different modalities for the locoregional part of restaging, involving response assessment of the primary tumor and regional lymph nodes (1). Detection of potentially emerged distant metastasis is the other crucial part of restaging after CRT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research